| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |